These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3492131)

  • 1. T-lymphocyte subsets and their cytotoxic capacity in patients with type I and type II diabetes mellitus.
    Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
    Allergol Immunopathol (Madr); 1986; 14(5):399-405. PubMed ID: 3492131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar alterations of lymphocyte subpopulations in type I and type II diabetes.
    Spooren PF; Vermes I; Soons JW
    Neth J Med; 1993 Jun; 42(5-6):163-7. PubMed ID: 8377873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reactions in patients with type I and with type II diabetes mellitus.
    Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
    Exp Clin Endocrinol; 1987 Aug; 89(3):354-62. PubMed ID: 3499333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
    Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
    Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological aspects of wound healing in patients with diabetes mellitus].
    Kim AIu; Morozov IuI; Kirdeĭ EG
    Klin Med (Mosk); 1994; 72(6):48-50. PubMed ID: 7898011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immunoregulatory T lymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies.
    Mascart-Lemone F; Delespesse G; Dorchy H; Lemiere B; Servais G
    Clin Exp Immunol; 1982 Feb; 47(2):296-300. PubMed ID: 6210472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
    Sobel DO; Creswell K
    Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of insulin on peripheral T-lymphocyte E-rosette function from normal and diabetic subjects.
    Cattaneo R; Saibene V; Margonato A; Pozza G
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):139-43. PubMed ID: 326272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic state does not influence lymphocyte subsets in type 1 diabetic patients.
    Buschard K; Birch K; Madsbad S; Röpke C
    Diabetes Res; 1988 Sep; 9(1):15-8. PubMed ID: 3071440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II].
    Salozhin KV; Sura VV; Nasonov EL; Korneeva MN; Smirnova OI
    Ter Arkh; 1989; 61(10):104-6. PubMed ID: 2609254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-specific cellular immunity in type I and type II diabetes.
    Fövenyi J; Tótpál K; Thaisz E; Garam T
    Exp Clin Endocrinol; 1984 Apr; 83(2):203-6. PubMed ID: 6539221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of T-lymphocyte subpopulations in juvenile-onset diabetics.
    Müller R; Kolb H; Kuschak D; Jörgens V; Gries FA
    Clin Exp Immunol; 1980 Jan; 39(1):130-5. PubMed ID: 6966986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of peripheral T-lymphocyte subpopulations in patients with insulin-dependent (type 1) diabetes mellitus.
    Buschard K; Röpke C; Madsbad S; Mehlsen J; Sørensen TB; Rygaard J
    J Clin Lab Immunol; 1983 Mar; 10(3):127-31. PubMed ID: 6221108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo determination of cell mediated immune response in diabetic patients using a multiple intradermal antigen dispenser.
    Pozzilli P; Pagani S; Arduini P; Visalli N; Cioccia GP; Negri M; Andreani D
    Diabetes Res; 1987 Sep; 6(1):5-8. PubMed ID: 3500820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte populations and responses to mitogens in infants of diabetic mothers.
    El Mohandes A; Touraine JL; Touraine F; Shukry AS; Salle B
    J Clin Lab Immunol; 1982 May; 8(1):25-9. PubMed ID: 6212685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heterogeneity of diabetes mellitus].
    Asfandiiarova NS; Kolcheva NG; Shatrova IV
    Ter Arkh; 1999; 71(12):49-52. PubMed ID: 10647203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous mixed lymphocyte reaction in man. VI. Deficiency of autologous mixed lymphocyte reaction in type I (insulin-dependent) diabetes mellitus.
    Gupta S; Fikrig S; Orti E
    J Clin Lab Immunol; 1983 Jun; 11(2):59-62. PubMed ID: 6224017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.